A. Brian Davis is a seasoned financial executive, including over 15 years of experience as a CFO for publicly traded, commercial and clinical‑stage biopharmaceutical companies, and nearly 30 years as a financial professional in the life sciences industry. Mr. Davis has raised over $600 million in public and private equity financings, including leading an initial public offering, and nearly $200 million in debt financings. Most recently, he was CFO at Verrica Pharmaceuticals, where he held managerial responsibility for executing equity and debt financings, analyst and shareholder relations, financial aspects of commercial launch preparation, business development, finance, accounting, tax, and treasury.

• 

  CFO: Chief Financial Officer in XyloCor Therapeutics

  Gene therapy for advanced coronary artery disease